Farther Finance Advisors »

Compass Therapeutics shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4k 388 3.50

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard S&p 500 Etf Etf (VOO)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Microsoft Corp Stock (MSFT)
Dimensional International Value Etf Etf (DFIV)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Oreilly Automotive Stock (ORLY)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares Core Total Usd Bond Market Etf Etf (IUSB)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)

View all positions for Farther Finance Advisors

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics